Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene ...

Once again, another working week will soon draw to a close and - along with it - the latest iteration of Pharmalot. Yes, you got that right. After a brief, but rewarding stay here at The Wall ...

Nonetheless, the Pharmalot campus is engulfed by a healthy amount of snow and still more is falling. This is a good time, then, to pick up a cup of stimulation and get busy foraging for ...

On Monday, Pharmalot's Ed Silverman shocked the pharmaceutical business by returning from vacation and announcing that his blog was no more. Over the past two years, Pharmalot grew into the ...

Pfizer will sell a biosimilar version of the Remicade rheumatoid arthritis treatment next month at a 15 percent discount off the list price of the brand-name drug.

Former Star-Ledger pharmaceuticals reporter Ed Silverman is considering reviving his blog, Pharmalot. He is now the legal owner of "Pharmalot.com" and is keeping the brand alive in the form of a ...

Drug makers spent $5.6 billion direct-to-consumer ads last year, a 9 percent increase, with Pfizer and Bristol-Myers Squibb leading the pack.

FLICKR, VELKR0 Ed Silverman’s Pharmalot blog is back, with a new home at The Wall Street Journal.Earlier this year (January 2), the blog was shut down by its former parent company, UBM Canon, which ...

WIKIMEDIA, KEN HAWKINS Each day, Ed Silverman, a long-time blogger and reporter, would start his morning post on Pharmalot with the chipper greeting, “Pharmalot, Pharmalittle,” plus a few words on the ...